FDA Inspection
Genentech, Inc.Genentech, Inc. – FDA Inspection, Oct 18, 2017
Record Details
This FDA Inspection record concerns Genentech, Inc., with an inspection on October 18, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f7ec06a9-d4c0-4fde-92d3-07345606d89f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1031803
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Genentech, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 27, 2024 | Not classified | Los Angeles District Office | |
| August 16, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 21, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 23, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 15, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Genentech, Inc.
- FDA Inspection 1250715 - 2024-08-27
- FDA Inspection 1249201 - 2024-08-16
- FDA Inspection 927320 - 2015-05-21
- FDA Inspection 833308 - 2013-05-23
- FDA Inspection 680551 - 2010-09-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.